XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (20,415) $ (9,204)
Adjustments to reconcile net loss to cash used in operating activities:    
Amortization and depreciation 924 590
Amortization of ROU Asset 240 149
Amortization of inventory step-up 978  
Unrealized loss on investment 1,702 140
Realized loss on short-term investment securities 108  
Gain on Panacea investment conversion   (2,548)
Accretion of non-cash interest expense (income) 206 (81)
Equity-based employee compensation expense 2,319 1,752
Change in working capital:    
Accounts receivable (1,126) 21
Inventory (2,822) (280)
Prepaid expenses and other assets (1,212) (2,307)
Accounts payable 693 (140)
Accrued expenses 59 (66)
Accrued payroll (1,521) 57
Accrued excise taxes and fees 386 160
Other liabilities (271) (513)
Net cash used in operating activities (19,752) (12,270)
Cash flows from investing activities:    
Acquisition of patents, trademarks, and licenses (250) (179)
Acquisition of property, plant and equipment (1,182) (388)
Acquisition, net of cash acquired and debt assumed (1,253)  
Investment in Change Agronomy Ltd. (682)  
Sales and maturities of short-term investment securities 38,880 19,037
Purchase of short-term investment securities (15,787) (58,137)
Net cash provided by (used in) investing activities 19,726 (39,667)
Cash flows from financing activities:    
Payment on note payable (804) (538)
Proceeds from note payable issuance 1,994 2,653
Other financing activities (6)  
Net proceeds from option exercise 174 1,259
Net proceeds from warrant exercise   11,782
Net proceeds from issuance of common stock   38,258
Taxes paid related to net share settlement of RSUs   (469)
Net cash provided by financing activities 1,358 52,945
Net increase in cash and cash equivalents 1,332 1,008
Cash and cash equivalents - beginning of period 1,336 1,029
Cash and cash equivalents - end of period 2,668 2,037
Non-cash transactions:    
Patent and trademark additions included in accounts payable 3  
Property, plant and equipment additions included in accounts payable 76 9
Property, plant and equipment additions included in accrued expenses   7
Right-of-use assets and corresponding operating lease obligations   497
Patent and trademark additions included in accrued expenses 43 32
Panacea investment conversion   $ 12,485
Stock issued in connection with acquisition 51,653  
Common stock issued in conjunction with litigation expense $ 51,653